On May 10,2022, Anbiping and Huawei signed a cooperation agreement in Guangzhou and officially joined the Shengteng Wanli Partnership Program. At the same time, a seminar was held on the project of pathological data + computing ecology cooperation. The two sides will build a pathology database based on Shengteng AI and a computer ecology collaboration program that includes trusted AI based on Shengsi MindSpore and leading technologies in interpretable AI to create a large model for histological AI pathology diagnosis, at the same time, we will jointly create self-innovative and competitive AI pathological diagnosis solutions to promote the industrialization of AI in the medical field, and support the prosperity and development of AI industry.

Huang Huafeng, director of the Guangzhou Economic and Technological Development Zone investment promotion agency,and Shao Chunkui,
chairman of the pathology branch of the Guangdong Medical Association, attended the ceremony and witnessed the signing of the contract

AMBIEN SIGNS CO-OPERATION AGREEMENT WITH HUAWEI

Liang Zongsheng, director and Deputy General Manager of Guangzhou Anbiping Pharmaceutical Technology Co. , Ltd. , and Tian Kunyang, vice president of Huawei Shengteng Computing, signed the contract on behalf of the two companies, huang Huafeng, director of the Guangzhou Economic and Technological Development Zone investment promotion agency, and Shao Chunkui, chairman of the pathology branch of the Guangdong Medical Association, attended the ceremony and witnessed the signing of the contract. According to the agreement, an biping will become an important participant and co-founder of the Shengteng AI ecosystem.

In the future, an biping will join hands with Huawei, based on the fundamental software and hardware platform of Shengteng AI, to make full use of the advantages of anbiping in the field of tumor screening and accurate diagnosis and in-depth service to the Department of Pathology of the hospital, and jointly create competitive pathological database and computing ecological solutions. In addition, the two sides will also carry out all-round cooperation in the field of AI medical, common prosperity Sheng Teng AI ecology, and promote industrial innovation and development.

The Guangzhou Economic and Technological Development Zone Director of the Investment Promotion Council, Huang Huafeng, attended the signing ceremony and attended the seminar, listening to the sharing of experts. In his speech, Huang Huafeng said that Huawei is a world-renowned technology company and an outstanding representative of Chinese Enterprises, and that Anbiping is a leader and pioneer in the field of pathological diagnosis in China, bilateral cooperation will be able to lead the profound changes in the industry, bringing greater development opportunities. It is hoped that the cooperation between the two sides will be solid and steady, and set a good example in promoting integrated development of the industry, AI-enabled precision medicine, and strengthening digital security and privacy protection. I wish the cooperation great success.

"The application of AI in pathology started later than that of imaging, which is characterized by a large amount of data, difficult storage and complex structure. However, the advantages of AI in image recognition are bound to become the future direction of pathology." Professor Shao Chunkui, director of the pathology branch of the Guangdong Medical Association, who is from the front line of medical treatment, is also looking forward to the collaboration, professor Shao said that the collaboration was supported by AI experts from Huawei and an biping, who had been working in the pathology industry for many years, and the government, it is expected that this cooperation will make a breakthrough in pushing the Department of pathology towards intelligentization.

MEDICAL HEALTH AND ARTIFICIAL INTELLIGENCE FUSION INNOVATION

Tian Kunyang, vice president of Shengteng Computing in Huawei, said that the industry's ecosystem is based on the fundamental software and hardware platform of Shengteng AI, join the AI field outstanding partners to create a“Build, share, win-win” ai industry. In medical fields such as cancer screening and pathological diagnosis, Huawei and ambien can complement each other's strengths. The two sides will work closely together to help the medical diagnosis industry move towards intelligence, and artificial intelligence will enable social development and industrial upgrading, bring value to the development of human society.

Tian Kunyang, vice president of Huawei Centeng Computing business

"In recent years, An Biping has concentrated on the construction of the four modernization of pathology and the joint construction of pathology departments in grassroots hospitals, and found that the shortage of pathologists and the lack of pathological knowledge are obstacles to the development of the whole pathology discipline." Liang Zongsheng, director and deputy general manager of Ambiping, believes that "digital construction is the root of solving a series of problems, and intelligence is the root of solving a series of problems."

Ambipin focuses on the research, development, production and service of tumor screening and pathological diagnosis products, and is one of the most complete and diversified production enterprises in the field of pathological diagnosis in China. Liang Zongsheng said that Ambiping attaches great importance to the cooperation with Huawei. In the future, Ambiping will deeply integrate its profound industry accumulation with Huawei's leading technology reserves, establish a multidimensional database that meets the diagnostic needs of pathology department, promote the digital and intelligent leap-forward development of pathology industry, strive to build industrial model projects, and promote the implementation of large-scale industries.

Liang Zongsheng, director and deputy general manager of Ambiping